Baidu
map

Lancet:全球200个国家地区近30年来高血压患病率、治疗和控制的变化情况

2021-08-25 Nebula MedSci原创

从1990 年至 2019 年 30-79 岁人群中高血压患者人数翻了一倍多!

高血压以及高血压前期和其他危险型高血压导致全球 8.50 万人死于中风、缺血性心脏病、其他血管疾病和肾脏疾病。在基层医院甚至是居家自测都可检测高血压,而且低成本治疗就有效控制高血压。

近日发表在国际顶级期刊柳叶刀上的一项研究,调研了全球 200 个国家和地区于1990 年至 2019 年期间的高血压患病率及其检测、治疗和控制情况

采用了 1990 年至 2019 年期间具有血压测量和治疗数据的代表性研究的 30-79 岁人群的数据。高血压定义:收缩压≥140 mmHg 和/或 舒张压≥ 90 mmHg,或服用高血压药物。采用贝叶斯分层模型评估高血压的患病率、既往确诊过的高血压患者比例(检出组)、服用高血压药物治疗的患者比例(治疗组)和血压控制在140/90 mmHg 以下的患者比例(对照组)。

2019年全球男性高血压的患病率

从1990 年至 2019 年 30-79 岁人群中高血压患者发生了翻倍女性患者 3.31→6.25 亿例;男性患者 3.17→6.52 亿例。2019年,加拿大和秘鲁的年龄标准化高血压发病率最低(男性和女性都是),此外,韩国、日本和西欧的部分国家(包括瑞士、西班牙和英国)的女性,以及几个中低收入国家(如厄立特里亚、孟加拉国、埃塞俄比亚和所罗门群岛)的男性的年龄标准化高血压发病率也较低。在中欧和东欧、中亚、大洋洲和拉丁美洲的两个国家的女性和9个国家的男性的高血压患病率超过 50%!

2019年全球女性高血压的治疗率

在全球范围内,2019 年有 59%的女性和 49%的男性患者既往已经确诊高血压;47%的女性和 38%的男性患者进行过抗高血压治疗。

2019年全球女性高血压的控制率

2019 年,女性患者和男性患者的高血压控制率分别是23%和18%。高血压治疗和控制率最高的国家有韩国、加拿大和冰岛(治疗率 > 70%, 控制率 > 50%),其次是美国、哥斯达黎加、德国、葡萄牙和台湾。女性患者治疗率<25%、男性患者治疗率<20%的国家有尼泊尔、印度尼西亚以及撒哈拉以南非洲和大洋洲的一些国家。北非、中亚和南亚以及东欧的部分国家的高血压控制率<10%。

自 1990 年以来,大多数国家的高血压治疗和控制率都有所提高,但撒哈拉以南非洲和大洋洲的大多数国家几乎没有变化。高收入国家、中欧以及一些中上收入国家和新增的高收入国家(包括哥斯达黎加、哈萨克斯坦、南非、巴西、智利、土耳其和伊朗)的改善幅度最大。

综上,在不同国家之间,高血压检测、治疗和控制的改善差异很大,一些中等收入国家现在的表现优于大多数高收入国家。通过初级预防降低高血压患病率和加强其治疗和控制的双重方法,不仅在高收入国家而且在中低收入国家都可以实现。

原始出处:

NCD Risk Factor Collaboration. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. The Lancet. August 24, 2021. https://doi.org/10.1016/S0140-6736(21)01330-1

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1831282, encodeId=5701183128243, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Mon Jan 17 10:12:03 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936224, encodeId=3b8a1936224d4, content=<a href='/topic/show?id=7dd710268033' target=_blank style='color:#2F92EE;'>#高血压患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102680, encryptionId=7dd710268033, topicName=高血压患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sat Oct 02 17:12:03 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250751, encodeId=36451250e5121, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Fri Aug 27 02:12:03 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011625, encodeId=99761011625b4, content=高血压知晓率的重要性, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Thu Aug 26 09:17:05 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034433, encodeId=7300103443304, content=顶刊就是不一样,质量很高,内容精彩!学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=goodbing, createdTime=Wed Aug 25 14:12:03 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011306, encodeId=24261011306fe, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40042504744, createdName=124a83fem50暂无昵称, createdTime=Wed Aug 25 11:55:39 CST 2021, time=2021-08-25, status=1, ipAttribution=)]
    2022-01-17 howi
  2. [GetPortalCommentsPageByObjectIdResponse(id=1831282, encodeId=5701183128243, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Mon Jan 17 10:12:03 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936224, encodeId=3b8a1936224d4, content=<a href='/topic/show?id=7dd710268033' target=_blank style='color:#2F92EE;'>#高血压患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102680, encryptionId=7dd710268033, topicName=高血压患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sat Oct 02 17:12:03 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250751, encodeId=36451250e5121, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Fri Aug 27 02:12:03 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011625, encodeId=99761011625b4, content=高血压知晓率的重要性, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Thu Aug 26 09:17:05 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034433, encodeId=7300103443304, content=顶刊就是不一样,质量很高,内容精彩!学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=goodbing, createdTime=Wed Aug 25 14:12:03 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011306, encodeId=24261011306fe, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40042504744, createdName=124a83fem50暂无昵称, createdTime=Wed Aug 25 11:55:39 CST 2021, time=2021-08-25, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1831282, encodeId=5701183128243, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Mon Jan 17 10:12:03 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936224, encodeId=3b8a1936224d4, content=<a href='/topic/show?id=7dd710268033' target=_blank style='color:#2F92EE;'>#高血压患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102680, encryptionId=7dd710268033, topicName=高血压患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sat Oct 02 17:12:03 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250751, encodeId=36451250e5121, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Fri Aug 27 02:12:03 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011625, encodeId=99761011625b4, content=高血压知晓率的重要性, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Thu Aug 26 09:17:05 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034433, encodeId=7300103443304, content=顶刊就是不一样,质量很高,内容精彩!学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=goodbing, createdTime=Wed Aug 25 14:12:03 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011306, encodeId=24261011306fe, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40042504744, createdName=124a83fem50暂无昵称, createdTime=Wed Aug 25 11:55:39 CST 2021, time=2021-08-25, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1831282, encodeId=5701183128243, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Mon Jan 17 10:12:03 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936224, encodeId=3b8a1936224d4, content=<a href='/topic/show?id=7dd710268033' target=_blank style='color:#2F92EE;'>#高血压患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102680, encryptionId=7dd710268033, topicName=高血压患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sat Oct 02 17:12:03 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250751, encodeId=36451250e5121, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Fri Aug 27 02:12:03 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011625, encodeId=99761011625b4, content=高血压知晓率的重要性, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Thu Aug 26 09:17:05 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034433, encodeId=7300103443304, content=顶刊就是不一样,质量很高,内容精彩!学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=goodbing, createdTime=Wed Aug 25 14:12:03 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011306, encodeId=24261011306fe, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40042504744, createdName=124a83fem50暂无昵称, createdTime=Wed Aug 25 11:55:39 CST 2021, time=2021-08-25, status=1, ipAttribution=)]
    2021-08-26 未来将来

    高血压知晓率的重要性

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1831282, encodeId=5701183128243, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Mon Jan 17 10:12:03 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936224, encodeId=3b8a1936224d4, content=<a href='/topic/show?id=7dd710268033' target=_blank style='color:#2F92EE;'>#高血压患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102680, encryptionId=7dd710268033, topicName=高血压患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sat Oct 02 17:12:03 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250751, encodeId=36451250e5121, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Fri Aug 27 02:12:03 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011625, encodeId=99761011625b4, content=高血压知晓率的重要性, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Thu Aug 26 09:17:05 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034433, encodeId=7300103443304, content=顶刊就是不一样,质量很高,内容精彩!学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=goodbing, createdTime=Wed Aug 25 14:12:03 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011306, encodeId=24261011306fe, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40042504744, createdName=124a83fem50暂无昵称, createdTime=Wed Aug 25 11:55:39 CST 2021, time=2021-08-25, status=1, ipAttribution=)]
    2021-08-25 goodbing

    顶刊就是不一样,质量很高,内容精彩!学到很多

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1831282, encodeId=5701183128243, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Mon Jan 17 10:12:03 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936224, encodeId=3b8a1936224d4, content=<a href='/topic/show?id=7dd710268033' target=_blank style='color:#2F92EE;'>#高血压患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102680, encryptionId=7dd710268033, topicName=高血压患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sat Oct 02 17:12:03 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250751, encodeId=36451250e5121, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Fri Aug 27 02:12:03 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011625, encodeId=99761011625b4, content=高血压知晓率的重要性, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Thu Aug 26 09:17:05 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034433, encodeId=7300103443304, content=顶刊就是不一样,质量很高,内容精彩!学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=goodbing, createdTime=Wed Aug 25 14:12:03 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011306, encodeId=24261011306fe, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40042504744, createdName=124a83fem50暂无昵称, createdTime=Wed Aug 25 11:55:39 CST 2021, time=2021-08-25, status=1, ipAttribution=)]
    2021-08-25 124a83fem50暂无昵称

    学习了

    0

相关资讯

EuroIntervention:肾动脉超声消融治疗难治性高血压长期随访结果公布(RADIANCE-HTN SOLO研究)

早期研究表明,射频去肾交感神经术可降低中度高血压患者的血压。我们研究了在不给予降压药物的情况下,一种替代技术——血管内超声肾交感神经消融术是否能降低高血压患者的动态血压。

CTCC 2021|孔祥清:高血压诊疗新靶点

2021年8月19日第三届“儒道心学”国际心血管病学会议上,南京医科大学第一附属医院孔祥清教授结合近年开展的相关临床研究,论述了肾周脂肪与血压调控的相关性。

Stroke:强化降血压,是否减缓小血管病进展?

在严重的脑小血管疾病中,强化降压与弥散张量成像或磁共振成像中白质损伤的进展无关

Ann Intern Med:肥胖症和高血压患者减肥手术的三年结果

减肥手术对肥胖症和高血压患者的中期影响仍不确定。为了确定Roux-en-Y胃绕道术(RYGB)与单纯药物治疗(MT)相比对血压(BP)的3年影响,研究人员进行了一项随机临床试验,结果发表于Ann In

J Clin Hyperten:每天快走几千步,高血压患者坚持 3 个月,血压竟下降了11 mmHg!

在世界范围内,高血压的患病率正逐年增加,预计2025年全球患者将增加15-20%,达到15亿以上。高血压也是心脑血管疾病和死亡的主要危险因素,每年有近千万人死于高血压。预防、控制高血压,可有效降低居民

EHJ:“宝藏药”沙库巴曲-缬沙坦作为治疗HFpEF合并难治性高血压患者的疗效

高血压和射血分数保留的心力衰竭(HFpEF)之间密切相关。

Baidu
map
Baidu
map
Baidu
map